Register entry
- Registered sites
- 1
- Active NDC listings
- 17
- Labeller names
- 2
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Carnegie Pharmaceuticals, LLC | 600 Delran Pkwy, Delran, New Jersey (NJ) 08075, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3011603634079839141 |
Catalogue
Drug listings by form and route
1717 active NDC listings: 17 human prescription drug. By marketing category: ANDA 17.
| Dosage form | NDCs |
|---|---|
| tablet | 8 |
| capsule | 4 |
| solution | 2 |
| tablet, film coated | 2 |
| powder, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 16 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| carnegie pharmaceuticals llc | 12 |
| carnegie pharmaceuticals, llc | 5 |
Catalogue
Marketed products
17| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| AMINOCAPROIC ACID | AMINOCAPROIC ACID | tablet, oral | 80005-128ANDA |
| AMINOCAPROIC ACID | AMINOCAPROIC ACID | tablet, oral | 80005-129ANDA |
| AMINOCAPROIC ACID | AMINOCAPROIC ACID | solution, oral | 80005-130ANDA |
| Clindamycin Phosphate | Clindamycin Phosphate Topical | solution, topical | 80005-131ANDA |
| ETRAVIRINE | ETRAVIRINE | tablet, oral | 80005-112ANDA |
| ETRAVIRINE | ETRAVIRINE | tablet, oral | 80005-113ANDA |
| FAMOTIDINE | FAMOTIDINE | powder, for suspension, oral | 80005-119ANDA |
| LOMUSTINE | LOMUSTINE | capsule, oral | 80005-114ANDA |
| LOMUSTINE | LOMUSTINE | capsule, oral | 80005-115ANDA |
| LOMUSTINE | LOMUSTINE | capsule, oral | 80005-116ANDA |
| Letrozole | Letrozole | tablet, film coated, oral | 80005-139ANDA |
| Primidone | Primidone | tablet, oral | 80005-117ANDA |
| Primidone | Primidone | tablet, oral | 80005-118ANDA |
| Rasagiline | Rasagiline mesylate | tablet, oral | 80005-141ANDA |
| Rasagiline | Rasagiline mesylate | tablet, oral | 80005-142ANDA |
| balsalazide disodium | balsalazide disodium | capsule, oral | 80005-126ANDA |
| vigabatrin | vigabatrin | tablet, film coated, oral | 80005-167ANDA |
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Carnegie Pharmaceuticals, LLC FDA approved?
- Carnegie Pharmaceuticals, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Carnegie Pharmaceuticals, LLC's drugs manufactured?
- The FDA register lists Delran, NJ. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling, repackaging.
- What drugs does Carnegie Pharmaceuticals, LLC make?
- 17 products are listed under Carnegie Pharmaceuticals, LLC in the openFDA NDC Directory, most often as tablet; capsule; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.